A single-loop recombinant pseudotyped-virus-based assay to detect HIV-1 phenotypic resistance

Archives of Virology
Shouli WuMeirong Xie

Abstract

HIV/AIDS is a leading public health concern throughout the world. Currently, treatment of HIV/AIDS still depends on highly active antiretroviral therapy (HAART); however, there is increasing evidence showing the emergence of resistance to antiretroviral drugs in HIV-1 strains, making ART less effective over time. Intensive monitoring of HIV-1 drug resistance is therefore of great importance to evaluate the current sensitivity of antiretroviral agents and is urgently needed. The aim of this study was to develop a single-loop recombinant pseudotyped-virus-based assay to detect phenotypic resistance in clinical HIV-1 strains. HIV-1 RNA was extracted from HIV-1-infected human plasma samples, and an approximately 3-kb fragment containing p7/p1/p6 cleavage sites and full-length protease (PR), reverse transcriptase (RT), thermonuclease (TNase), and integrase (1-280 aa) genes was amplified by nested RT-PCR. A retroviral vector was constructed using the HIV-1 infectious molecular clone pLWJ to test antiretroviral drug susceptibility. pLWJ-SV40-Luc contained a luciferase expression cassette inserted within a deleted region of the envelope (env) gene as an indicator gene. Resistance test vectors (RTVs) were constructed by incorporating am...Continue Reading

References

Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·J H Condra
Sep 29, 1999·JAMA : the Journal of the American Medical Association·S J LittleD D Richman
Jan 27, 2000·JAMA : the Journal of the American Medical Association·C C CarpenterP A Volberding
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·C J PetropoulosJ M Whitcomb
Mar 5, 2004·The New England Journal of Medicine·François Clavel, Allan J Hance
Apr 21, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Bertran AuvertBrian Williams
Dec 23, 2004·Endocrine-related Cancer·Alistair Ring, Mitch Dowsett
Dec 6, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H H HirschM Battegay
Jul 26, 2006·Pharmacotherapy·Frank J Piacenti
Jan 5, 2008·The Journal of Antimicrobial Chemotherapy·Robert W Burgoyne, Darrell H S Tan
Jul 30, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ravindra GuptaDeenan Pillay
Oct 22, 2008·Lancet·Kong-Lai ZhangDong-Bao Yu
Mar 9, 2010·Journal of the International AIDS Society·Reuben GranichBrian Williams
Dec 22, 2011·Current Opinion in HIV and AIDS·Fernando MaltêzCristina Valente
Apr 5, 2012·Cold Spring Harbor Perspectives in Medicine·Eric J Arts, Daria J Hazuda
Aug 9, 2012·Current Opinion in HIV and AIDS·Daria J Hazuda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.